In today’s Pharma Pulse, the FDA launches its "PreCheck" pilot to speed up domestic factory approvals, while new SELECT trial data shows that semaglutide significantly slashes hospital admission rates ...

In today’s Pharma Pulse, extreme weather tests the resilience of community pharmacies, while CMS proposes a near-flat 0.09% update for Medicare Advantage and Part D payments in 2027.

2023 should have been a recovery year for the supply chain, following the major disruptions of 2022, but problems remained with parts shortages and shipping problems. Will 2024 be any better? A group ...

The report surveyed 3,650 C-suite leaders and 3,350 employees, including 400 Chief Operating Officers, Chief Supply Chain & ...

In the past decade, supply chains have become more complex and globalised. With the rise of e-commerce and the 24/7 demand for goods and services, organisations are expected to contend with a more ...